Showing results (241-250 of 361) with videos related to
Sort By:
Pageof 37
Anticancer Research|March 14, 2013
Phase II study of carboplatin and weekly irinotecan combination chemotherapy in recurrent ovarian cancer: a Kansai clinical oncology group study (KCOG0330)Hiroshi Tsubamoto, Ryuji Kawaguchi, Kimihiko Ito, et al.Journal of Cutaneous Pathology|January 12, 2007
Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's diseaseHoujun Liu, Kazunori Urabe, Hiroshi Uchi, et al.The Journal of Investigative Dermatology|July 15, 2011
Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: the basis of its anti-inflammatory effectGaku Tsuji, Masakazu Takahara, Hiroshi Uchi, et al.Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine|November 20, 2012
Useful method to monitor the physiological effects of alcohol ingestion by combination of micro-integrated laser Doppler blood flow meter and arm-raising testWataru Iwasaki, Hirofumi Nogami, Hiroki Ito, et al.The Journal of Hand Surgery|August 17, 2023
The Effect of Elbow Flexion On Valgus Carrying AngleTyler John Wilps, Calvin K Chan, Satoshi Yamakawa, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2014
Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancerSatoshi Takeuchi, Benjapa Khiewvan, Patricia S Fox, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 4, 2014
Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patientsSatoshi Takeuchi, Aparna Balachandran, Mouhammed Amir Habra, et al.Case Reports in Oncology|July 8, 2011
A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line ChemotherapySatoshi Takeuchi, Rio Honma, Jun Taguchi, et al.BMC Cancer|November 7, 2013
Assessment of early changes in 3H-fluorothymidine uptake after treatment with gefitinib in human tumor xenograft in comparison with Ki-67 and phospho-EGFR expressionSongji Zhao, Yuji Kuge, Yan Zhao, et al.Anticancer Research|July 5, 2022
Risk Factor Analysis for the Occurrence of Severe Adverse Effects in Eribulin TreatmentYoshitaka Saito, Yoh Takekuma, Takashi Takeshita, et al.Pageof 37